RCOG World Congress 2023

Therapeutic Efficacy of Colpocleisisin the Treatment of Severe Pelvic Organ Prolapse

Mr Kiron Bhal (Consultant Urogynaecologist), Dr Olivia Jia Yhi Tan, Dr Elsie Jia ZhiTan

University Hospital of Wales, Cardiff.

Introduction:

Women with vault or uterine prolapse who intend to be sexually inactive and at a higher risk of postoperative complications are offered colpocleisis (NICE, 2019).

Aim:

This study aims to evaluate the overall therapeutic efficacy of colpocleisis in treating pelvic organ prolapse (POP).

Methods:

•Retrospective study of 38 patients who had undergone colpocleisesbetween September 2015 to December 2019.

•30 patients met inclusion criteria. Data reviewed such as post-operative recurrence, reoperation and complications.

•13 patient responses obtained from telephone questionnaire. Global Impression of Improvement (PGI-I) Scale used.

•Questions asked: 1) Severity of of symptoms pre-op, 2) Any improvement in symptoms post-op, 3) regret rate and, 4) Overall satisfaction ratings.

Results:

Conclusion:

The results from the study and patient questionnaire proves that colpocleisis is a safe and effective surgical procedure in the treatment of pelvic organ prolapse. It is associated with low complications, high patient satisfaction and overall improvement of symptoms post-operatively.

References:

National Institute for Health and Care Excellenc. Urinary Incontinence and Pelvic Organ Prolapse in Women: Management [Internet]. 2019. Available from: https://www.nice.org.uk/guidance/ng123/resources/urinary-incontinence-and-pelvic-organ-prolapse-in-women-management-pdf-66141657205189

RCOG World Congress 2023

Therapeutic Efficacy of Colpocleisis in Treating Pelvic Organ Prolapse: A Retrospective Study

Poster Presenter

Authors

Affiliations

Part of Topic